抵当汤临床及实验研究进展

Recent Development of Didang Decoction in Clinical Treatment and Experimental Studies

介绍抵当汤近年来的临床应用及实验进展。作者通过收集现代有关抵当汤的中西医学研究文献,将抵当汤在前列腺肥大和前列腺增生、不稳定性心绞痛、糖尿病、下肢深静脉血栓形成、栓塞性静脉炎、外伤后便秘、溃疡性结肠炎、脑出血等方面的临床研究与应用情况和抗癌及增强机体免疫功能、改善糖尿病及其并发症、减少动脉粥样硬化、抗冠心病PTCA术后再狭窄、改善脑血管供血、提高抗炎性因子水平、保护脑细胞功能等方面作用的实验研究情况加以整理,认为目前的研究存在着诸多问题,多数报道属小样本及零星的各案分析,缺乏大样本、多中心、随机双盲对照的前瞻性研究。今后对抵当汤应侧重于实验室研究,以增强其科学性和可靠性。

Didang Decoction from ＇Shanghanlun＇ is onsisted of Shuizhi,Mengchong,Taoren,Daihuang.The collected the modern medical research literature on the decoction,benign prostatic hypertrophy,unstable angina,diabetes,deep vein thrombosis,thrombotic phlebitis,post-traumatic constipation,ulcerative colitis,cerebral hemorrhage,anti-cancer,immune function,diabetic complications,atherosclerosis,restenosis after PTCA against coronary heart disease,improving brain blood vessels,anti-inflammatory cytokines,protection for function of brain cells,and other aspects of the decoction.help expand Didangtang applications and related diseases.However,the current researches are mostly samll sized studies,lack of multi-centered double-blined studies.It is recommendated that the future studies should be more scientific and reliable.